A group of advisors to the Food and Drug Administration on Friday reframed a proposed approval of BioNTech and Pfizer's COVID-19 booster for the general population, and it instead recommended authorization of an additional dose of the vaccine to people at least 65 years old and those at high risk for severe disease.
Read More...
New Research Busts Popular Myths About Innovation
Some technologies improve much faster than others, and they do so at a more or less steady pace, regardless of individual breakthroughs and inventors. This should change how investors, policy makers and anyone choosing a c…
Add Comment